+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Plasma Therapy - Global Strategic Business Report

  • PDF Icon

    Report

  • 275 Pages
  • June 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 4845762
The global market for Plasma Therapy was estimated at US$646.0 Million in 2025 and is projected to reach US$1.1 Billion by 2032, growing at a CAGR of 7.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Plasma Therapy Market - Key Trends and Drivers Summarized

Healing from Within: The Promises and Processes of Plasma Therapy

Plasma therapy, also known as platelet-rich plasma (PRP) therapy, is a medical treatment that utilizes the patient’s own blood to accelerate healing in various parts of the body. The process begins with a blood draw, from which the plasma, rich in platelets and growth factors, is isolated through centrifugation. This concentrated plasma is then injected into the injured or affected area. Platelets play a crucial role in clotting and tissue repair, and the growth factors they release can stimulate cell proliferation, tissue regeneration, and healing. This therapy is increasingly popular in fields like orthopedics, sports medicine, and dermatology for its potential to enhance recovery and reduce inflammation.

How Is Plasma Therapy Applied in Different Medical Fields?

Plasma therapy is utilized across a range of medical fields due to its regenerative properties. In orthopedics and sports medicine, PRP injections are used to treat chronic tendon injuries, such as tennis elbow and Achilles tendinitis, as well as acute injuries like ligament sprains and muscle strains. These injections can also aid in the recovery from surgeries, enhancing the healing process and reducing downtime. In dermatology, plasma therapy is employed for facial rejuvenation, reducing wrinkles, and improving skin texture through procedures commonly known as the “vampire facial.” Additionally, PRP is used in hair restoration treatments, promoting hair growth in patients experiencing hair loss. The versatility of plasma therapy makes it a valuable tool in both restorative and aesthetic medicine, offering patients a natural and effective treatment option.

What Are the Current Trends in Plasma Therapy Research and Applications?

The field of plasma therapy is continuously evolving, driven by ongoing research and clinical advancements. One significant trend is the increasing use of PRP in combination with other treatments, such as stem cell therapy and microneedling, to enhance therapeutic outcomes. Researchers are also exploring the efficacy of plasma therapy in new areas, such as treating degenerative joint diseases like osteoarthritis and promoting wound healing in diabetic patients. Advances in PRP preparation techniques are improving the consistency and potency of the treatments, making them more reliable and effective. Additionally, there is a growing emphasis on understanding the specific components of PRP and how different concentrations of platelets and growth factors can be optimized for various conditions. These trends reflect the dynamic nature of plasma therapy research, aiming to broaden its applications and improve patient outcomes.

What Factors Are Driving the Growth in the Plasma Therapy Market?

The growth in the plasma therapy market is driven by several factors, reflecting the increasing demand for innovative and effective medical treatments. Rising awareness of the benefits of PRP therapy, coupled with its minimally invasive nature and lower risk of side effects, is attracting more patients and healthcare providers. Technological advancements in PRP preparation and delivery methods are enhancing the efficacy and reliability of treatments, further boosting their popularity. The expanding applications of plasma therapy in diverse medical fields, including orthopedics, dermatology, and hair restoration, are contributing to market growth. Additionally, the growing trend towards regenerative medicine and personalized treatments is driving interest in PRP as a natural and patient-specific therapy. Increased healthcare spending and the expansion of medical infrastructure in developing regions are also supporting market growth, making these advanced treatments more accessible. These factors collectively ensure robust growth in the plasma therapy market, highlighting its significant potential in modern healthcare.

Report Scope

The report analyzes the Plasma Therapy market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (Pure PRP Type, Leukocyte-Rich PRP Type, Pure Platelet-Rich Fibrin Type, Leukocyte-Rich Fibrin Type); Source (Autologous Source, Allogenic Source); Application (Wound Care Application, Dermatology & Aesthetics Application, Orthopedics Application, Other Applications); End-Use (Hospitals & ASCs End-Use, Specialty Clinics End-Use, Research Institutes End-Use, Other End-Uses)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Pure PRP Type segment, which is expected to reach US$439.4 Million by 2032 with a CAGR of a 8.5%. The Leukocyte-Rich PRP Type segment is also set to grow at 5.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $191.1 Million in 2025, and China, forecasted to grow at an impressive 7.1% CAGR to reach $187.5 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Plasma Therapy Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Plasma Therapy Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Plasma Therapy Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Active Sports Medicine, Alkahest, Inc., Bio Products Laboratory Ltd., Biolife Plasma Services, CSL Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Plasma Therapy market report include:

  • Active Sports Medicine
  • Alkahest, Inc.
  • Bio Products Laboratory Ltd.
  • Biolife Plasma Services
  • CSL Ltd.
  • Excelsior Orthopaedics
  • Glofinn Oy
  • Juventix
  • Octapharma AG
  • Origin, Inc.

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 1,621 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Plasma Therapy - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Propels Market Growth
  • Advances in Plasma-Derived Therapies Drives Adoption
  • Rising Demand for Immunoglobulin Therapies Expands Market Opportunities
  • Growth in Geriatric Population Strengthens Business Case for Plasma Therapy
  • Development of Novel Plasma Treatments Spurs Market Expansion
  • Expansion of Blood Plasma Donation Centers Generates Demand
  • Increasing Focus on Personalized Medicine Accelerates Market Growth
  • Enhanced Safety and Efficacy of Modern Plasma Therapies Sustains Market Demand
  • Rising Investments in Plasma Research and Development Expands Addressable Market
  • Technological Innovations in Plasma Fractionation Strengthens Market Position
  • Development of Recombinant Plasma Products Generates Market Opportunities
  • Growth in Hemophilia and Coagulation Disorder Treatments Propels Market Growth
  • Increasing Demand for Convalescent Plasma Therapy Sustains Market Expansion
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 2: World Historic Review for Plasma Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 3: World 13-Year Perspective for Plasma Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 4: World Plasma Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 5: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Pure PRP Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Pure PRP Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Pure PRP Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Leukocyte-Rich PRP Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Leukocyte-Rich PRP Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Leukocyte-Rich PRP Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Pure Platelet-Rich Fibrin Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Pure Platelet-Rich Fibrin Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Pure Platelet-Rich Fibrin Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Leukocyte-Rich Fibrin Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Leukocyte-Rich Fibrin Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Leukocyte-Rich Fibrin Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Autologous Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Autologous Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Autologous Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Allogenic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Allogenic Source by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Allogenic Source by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Wound Care Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Wound Care Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Wound Care Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Dermatology & Aesthetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Dermatology & Aesthetics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Dermatology & Aesthetics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Orthopedics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Orthopedics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Orthopedics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Hospitals & ASCs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Hospitals & ASCs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Hospitals & ASCs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Plasma Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLD
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Active Sports Medicine
  • Alkahest, Inc.
  • Bio Products Laboratory Ltd.
  • Biolife Plasma Services
  • CSL Ltd.
  • Excelsior Orthopaedics
  • Glofinn Oy
  • Juventix
  • Octapharma AG
  • Origin, Inc.

Table Information